Ivermectin Treatment Coverage Validation in Two Onchocerciasis Endemic Districts in Ethiopia: A Community-Based Cross-Sectional Study, 2019

BACKGROUND: Onchocerciasis is the second leading cause of blindness globally next to trachoma, thus eliminating the infection is an important health priority. It is estimated that 15.7 million people are at risk of infection in different parts of Ethiopia. Mass drug administration with ivermectin at...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Multidiscip Healthc
Glavni autori: Churko, Chuchu, Yihune, Manaye, Teshome, Abinet, Chisha, Yilma, Getachew, Birhanu, Sleshi, Markos, Asfaw, Mekuria Asnakew, Shibiru, Tamiru, Ayele, Nebiyu Negussu, Seife, Fikre, Zerdo, Zerihun, Bekele Kassahun, Alemayehu
Format: Artigo
Jezik:Inglês
Izdano: Dove 2021
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7822083/
https://ncbi.nlm.nih.gov/pubmed/33500622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JMDH.S288239
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items